Ranbaxy receives US FDA Form 483 at Indian API plant

/in /by

Ranbaxy receives US FDA Form 483 at Indian API plant

By Dan Stanton+, 13-Jan-2014

An Indian API facility has received a form 483 from the US FDA in the latest setback for troubled drugmaker Ranbaxy.

http://www.in-pharmatechnologist.com/Ingredients/Ranbaxy-receives-US-FDA-Form-483-at-Indian-API-plant